These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16986713)

  • 1. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement].
    Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K
    Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of multicentric Castleman's disease with pulmonary involvement].
    Morise M; Shimomoto H; Honda T; Mori Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Jan; 41(1):59-65. PubMed ID: 12693008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease].
    Harada N; Sayama K; Tanaka K; Hasegawa N; Okamoto S; Hayashi Y; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2010 Feb; 48(2):145-50. PubMed ID: 20184247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy.
    Yuzuriha A; Saitoh T; Koiso H; Mitsui T; Uchiumi H; Yokohama A; Handa H; Kojima M; Tsukamoto N; Karaswa M; Murakami H; Nojima Y
    Acta Haematol; 2011; 126(3):147-50. PubMed ID: 21757886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case report.
    Mohammed A; Janku F; Qi M; Kurzrock R
    J Med Case Rep; 2015 Feb; 9():45. PubMed ID: 25884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
    Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
    Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of multicentric Castleman's disease with pulmonary involvement].
    Taniguchi H; Inomata M; Abo H; Izumi S
    Nihon Kokyuki Gakkai Zasshi; 2009 Jun; 47(6):496-500. PubMed ID: 19601526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N; Sasai M; Shima Y; Nakagawa M; Matsumoto T; Shirai T; Kishimoto T; Yoshizaki K
    Blood; 2000 Jan; 95(1):56-61. PubMed ID: 10607684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinicopathological analysis of pulmonary parenchymal involvement of multicentric giant lymph node hyperplasia (Castleman's disease)].
    Tian X; Ge L; Feng R; Liu T; Huang H; Xu Z; Xu W; Liu H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):337-42. PubMed ID: 25011507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
    Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
    AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
    Takeuchi N; Arai T; Kitaichi M; Inoue Y
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
    Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
    BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA nephropathy associated with Castleman disease with cutaneous involvement.
    Komatsuda A; Wakui H; Togashi M; Sawada K
    Am J Med Sci; 2010 May; 339(5):486-90. PubMed ID: 20335784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical cellular disorders.
    McClain KL; Natkunam Y; Swerdlow SH
    Hematology Am Soc Hematol Educ Program; 2004; ():283-96. PubMed ID: 15561688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studies.
    Jerkeman M; Lindén O
    Eur J Haematol; 2016 May; 96(5):541-3. PubMed ID: 26256458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.
    Angenendt L; Kerkhoff A; Wiebe S; Mikesch JH; Rudat A; Wötzel F; Wenning C; Schliemann C; Kessler T; Schäfers M; Wardelmann E; Stelljes M; Berdel WE
    Ann Hematol; 2015 Jul; 94(7):1241-3. PubMed ID: 25791243
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.
    Kanda J; Kawabata H; Yamaji Y; Ichinohe T; Ishikawa T; Tamura T; Furukawa Y; Kimura T; Kita T; Uchiyama T
    Int J Hematol; 2007 Apr; 85(3):207-11. PubMed ID: 17483056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicentric Castleman's disease accompanied with both lymphoid interstitial pneumonia and interstitial nephritis].
    Sato T; Wakabayashi Y; Hirasawa A; Tashiro Y; Nishikawa T; Chiba S
    Rinsho Ketsueki; 1994 Nov; 35(11):1322-8. PubMed ID: 7823399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
    Fujiwara H; Mise N; Ishimoto Y; Kotera N; Tanaka M; Tanaka S; Kurita N; Fujii A; Yamaguchi Y; Sugimoto T
    Nihon Jinzo Gakkai Shi; 2011; 53(2):189-94. PubMed ID: 21516705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.